| Hou et al, 2007 (24) | Retrospective observational cohort study | Patients admitted to the intensive care units with septic shock | Metaraminol used together with dopamine. Haemodynamic variables and impact on renal function evaluated as outcome measures. |
|
| Abu Sardaneh et al, 2021 (34) | A retrospective cohort study to determine the dose equivalent between metaraminol and noradrenaline | Patients with shock of any cause in the intensive care unit. | The conversion dose ratio between continuous infusion metaraminol and norepinephrine ranged between 8 and 13 in the primary and sensitivity analyses. |
|
| Abu Sardaneh et al., 2021 (21) | A retrospective observational study | Patients with shock of any cause in the intensive care unit. | Metaraminol was the most commonly used first line vasopressor. The study reported on the practice and did not focus on outcomes. |
|
| Abu Sardaneh et al, 2021 (23) | A retrospective matched observational study | Patients with shock of any cause in the intensive care unit. | In critically ill patients, metaraminol used alongside norepineohrine may be associated with a longer time to resolution of shock compared with those who only receive norepinephrine. |
|
| Da Silva and Furtado, 2018 (22) | A case report | Anaphylactic shock | Metaraminol mentioned as a vasopressor in shock |
|
| Anderson and Chatha, 2017 (25) | Literature review | Metaraminol use in the Emergency Department | Concluded that it is widely used in the emergency department setting with little evidence to support the practice. |
|
| Hayward et al, 2016 (26) | A review of practice | Review of medications used by Australian aeromedical prehospital and retrieval service. | Metaraminol only briefly mentioned as a treatment option utilised by the Australian pre-hospital service |
|
| Redmond et al, 2013 (27) | A case report | Takotsubo cardiomyopathy | A patient, suffering from at that point undiagnosed Takotsubo cardiomyopathy progressed to pulseless ventricular tachycardia following bolus administration of metaraminol. |
|
| Isbister and Duffull, 2009 (28) | A case report | Quetiapine overdose | Metaraminol used successfully to maintain blood pressure (as opposed to conventional vasopressors) |
|
| Dewachter et al, 2007 (29) | A review of current practice | Perioperative anaphylaxis | Metaraminol briefly mentioned as a vasopressor used to treat hypotension |
|
| Brown, 2005 (30) | Review of management of anaphylaxis | Anaphylactic shock | Metaraminol briefly mentioned as a vasoconstrictor in shock. |
|
| Wood et al, 2005 (31) | A case report | Amlodipine overdose | Metaraminol used successfully to maintain blood pressure (as opposed to conventional vasopressors) |
|
| Holmes, 2005 (32) | Opinion piece | Opinion piece on vasopressors in the Intensive Care | Metaraminol mentioned alongside other vasopressors used to treat hypotension |
